Precisely in this regard, several papers analyzed in the literature have proposed to always perform an immunolabelling with Smooth Actin muscle (SMA), or p63 p CK5/6, to study the continuity of the myoepithelium, similar to what happens in the evaluation of breast cancer. The gene discussed is KRT5; the disease is breast cancer.